Let's Get Serious About Scientific Misconduct

So, with the public's trust in its institutions already crumbling, the scientific community must get serious about the way it deals with alleged fraud and misconduct. To be convinced of this, we can call to mind the protracted, torturous unwinding of the notorious Baltimore case. As most of us are aware, it was back in 1986 that a paper bearing the name of Nobelist David Baltimore was published in the journal Cell (45:247, 1986). It contained an important conclusion based on data that did not

Written byGordon Muir
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

So, with the public's trust in its institutions already crumbling, the scientific community must get serious about the way it deals with alleged fraud and misconduct. To be convinced of this, we can call to mind the protracted, torturous unwinding of the notorious Baltimore case. As most of us are aware, it was back in 1986 that a paper bearing the name of Nobelist David Baltimore was published in the journal Cell (45:247, 1986). It contained an important conclusion based on data that did not exist. A young postdoc--Margot O'Toole--blew the whistle and, for her efforts, was mugged by a powerful establishment that closed ranks. Eventually, she lost her job, becoming, as she put it, "subjected to five years of slander and libel from Dr. Baltimore [and colleagues]" (Nature, 351:180, 1991). Pretty bad--but it gets worse.

What most people, including scientists, don't know is that the editors of Science and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies